- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04588636
Behavioral Therapy and Self-care vs Thermoformed Occlusal Splints in the Treatment of Masticatory Muscles Pain
Behavioral Therapy and Self-care vs Thermoformed Occlusal Splints in the Treatment of Masticatory Muscles Pain: a Controlled Clinical Trial.
Study Overview
Status
Conditions
Detailed Description
Materials and method This randomized controlled clinical trial was conducted between October 2017 and January 2018 at the Dental Clinic of the Andrés Bello University (Viña del Mar, Chile). The study subjects were recruited from the universe of patients seeking treatment for jaw pain at the School of Dentistry. All subjects were informed about the study by their operator and gave their written consent before starting the study. The protocol, design and implementation were approved by the Scientific Ethics Committee of the Faculty of Dentistry of the Andrés Bello University, Viña del Mar, Chile (Folio No. 033, October 2017). Which was in accordance with the latest version of the Declaration of Helsinki of the World Medical Association (World Medical Association Declaration of Helsinki, 2013).
Sample Size Calculation It was calculated according to a confidence level of 95% and a statistical power of 80%. Based on a previous study by Niemelä et al. (Niemelä et al., 2012) it was determined that the variance of the main variable (masticatory muscle pain) of the reference group is 2.6. In turn, the pain variable was measured on the visual analog scale (VAS), where a minimum clinically relevant difference was considered if a 3.5 point decrease was achieved on the VAS scale with respect to treatment, a reference that was also considered in this study.
Randomization and interventions. After meeting the inclusion and exclusion criteria, the subjects were randomly assigned to four groups through a computationally generated sequence "list randomizer" developed by random.org.
Evaluation methods The initial evaluation, to determine the degree of involvement of axis I, was carried out following the symptom questionnaire and clinical examination guidelines according to the DC / TMD protocol. Additionally, the questionnaire for the chronic pain degree scale (GCPS v2.0) and the functional limitation scale (JFLS-20) of axis II of the DC / TMD protocol were applied. In turn, an intraoral clinical examination was performed to exclude pain of dental origin. No subject was excluded for odontogenic pain.
Statistic analysis The demographic characteristics of the sample were reported descriptively. The data studied were tested to determine normality by using the Shapiro-Wilk and Doornik-Hansen tests, data that were parametric, so they were analyzed with a mixed ANOVA test, a factorial part and a repeated means part for the variables degree of chronic pain, masticatory muscle pain, mandibular range of motion, functional limitation and occlusal discomfort. The level of significance used was established at p 0.05. All statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 17 software (IBM, Chicago, USA).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Viña Del Mar, Chile, 2520000
- Universidad Nacional Andres Bello
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 40 years
- Presence of myalgia of the masticatory muscles with or without limitation of the mouth opening according to DC / TMD diagnostic criteria
Exclusion Criteria:
- Painful joint TMD
- History of treatment for TMD
- Recent history of facial or cervical trauma
- Current orthodontic treatment
- Tooth mobility secondary to periodontal disease
- Subjects with loss of more than two teeth other than third molars and / or premolars due to orthodontic indication
- Subjects with systemic musculoskeletal diseases or who are under analgesic treatment
- Subjects with a diagnosed intellectual disability who cannot express their will to participate in scientific research as established by law 20.584 of Chile
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Behavioral and self-care therapy control group
Subjects received verbal and written information on the etiology and prognosis of TMDs.
In addition, advice on habits and behavior changes, relaxation techniques, sleep hygiene, diet modification, thermotherapy, encouragement to practice social and aerobic activities, and how to prevent risk factors and bad habits.
|
It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior.
The therapy uses behavioral and self-care techniques to identify, correct and prevent behaviors or situations capable of altering the subject's state
Other Names:
|
Active Comparator: Rigid occlusal splint group
Subjects in this group received behavioral and self-care therapy, in combination with a rigid occlusal splint
|
It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior.
The therapy uses behavioral and self-care techniques to identify, correct and prevent behaviors or situations capable of altering the subject's state
Other Names:
Occlusal splint formed in a vacuum from rigid individual sheets of 2 mm thick polyethylene terephthalate (Biolon, Dreve, Unna, Germany).
Other Names:
|
Active Comparator: Soft occlusal splint group
Subjects in this group received behavioral and self-care therapy, in combination with a soft occlusal splint
|
It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior.
The therapy uses behavioral and self-care techniques to identify, correct and prevent behaviors or situations capable of altering the subject's state
Other Names:
Occlusal splint formed in a vacuum from 3 mm thick individual soft sheets of ethyl vinyl acetate (Drufosoft, Dreve, Unna, Germany).
Other Names:
|
Placebo Comparator: Non-occlusive splint group
Subjects in this group received behavioral and self-care therapy, in combination with a non-occlusive splint
|
It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior.
The therapy uses behavioral and self-care techniques to identify, correct and prevent behaviors or situations capable of altering the subject's state
Other Names:
non-occlusive splint formed under vacuum from individual sheets of rigid polyethylene terephthalate 2 mm thick (Biolon, Dreve, Unna, Germany), from which the occlusal surfaces were cut and incisal edges, allowing the usual occlusal contact of each subject.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Masticatory muscle pain initial evaluation
Time Frame: It was applied in the initial evaluation
|
Pain intensity was measured using a visual analog scale.
Subjects were asked to mark the intensity of pain perceived at the time of examination.
This scale has a score from 0 to 10, with 10 being the greatest pain experienced by the patient
|
It was applied in the initial evaluation
|
Masticatory muscle pain at 2 weeks
Time Frame: It was applied in week 2 of intervention.
|
Pain intensity was measured using a visual analog scale.
Subjects were asked to mark the intensity of pain perceived at the time of examination.
This scale has a score from 0 to 10, with 10 being the greatest pain experienced by the patient
|
It was applied in week 2 of intervention.
|
Masticatory muscle pain at 6 weeks
Time Frame: It was applied in week 6 of intervention.
|
Pain intensity was measured using a visual analog scale.
Subjects were asked to mark the intensity of pain perceived at the time of examination.
This scale has a score from 0 to 10, with 10 being the greatest pain experienced by the patient
|
It was applied in week 6 of intervention.
|
Masticatory muscle pain at 10 weeks
Time Frame: It was applied in week 10 of intervention.
|
Pain intensity was measured using a visual analog scale.
Subjects were asked to mark the intensity of pain perceived at the time of examination.
This scale has a score from 0 to 10, with 10 being the greatest pain experienced by the patient
|
It was applied in week 10 of intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mandibular range of movement initial evaluation
Time Frame: It was applied in the initial evaluation
|
Maximum opening of the mouth in an autonomous and comfortable way, that is, without feeling pain and not assisted by the operator, measured in millimeters from incisal edge to incisal edge in the anterior teeth, compensating for the overbite
|
It was applied in the initial evaluation
|
Mandibular range of movement at 2 weeks
Time Frame: It was applied in week 2 of intervention.
|
Maximum opening of the mouth in an autonomous and comfortable way, that is, without feeling pain and not assisted by the operator, measured in millimeters from incisal edge to incisal edge in the anterior teeth, compensating for the overbite
|
It was applied in week 2 of intervention.
|
Mandibular range of movement at 6 weeks
Time Frame: It was applied in week 6 of intervention.
|
Maximum opening of the mouth in an autonomous and comfortable way, that is, without feeling pain and not assisted by the operator, measured in millimeters from incisal edge to incisal edge in the anterior teeth, compensating for the overbite
|
It was applied in week 6 of intervention.
|
Mandibular range of movement at 10 weeks
Time Frame: It was applied in week 10 of intervention.
|
Maximum opening of the mouth in an autonomous and comfortable way, that is, without feeling pain and not assisted by the operator, measured in millimeters from incisal edge to incisal edge in the anterior teeth, compensating for the overbite
|
It was applied in week 10 of intervention.
|
Mandibular functional limitation initial
Time Frame: It was applied in the initial evaluation
|
Scale in charge of globally assessing masticatory limitation, vertical mobility limitation, verbal and non-verbal communication limitation, included within a 20-item instrument thanks to the survey of mandibular functional limitation of the DC / TMD.
This scale has a score of 0 to 10, with 10 being a severe limitation
|
It was applied in the initial evaluation
|
Mandibular functional limitation final
Time Frame: It was applied in week 10 of intervention.
|
Scale in charge of globally assessing masticatory limitation, vertical mobility limitation, verbal and non-verbal communication limitation, included within a 20-item instrument thanks to the survey of mandibular functional limitation of the DC / TMD.
This scale has a score of 0 to 10, with 10 being a severe limitation
|
It was applied in week 10 of intervention.
|
Grade of chronic pain
Time Frame: It was applied in the initial evaluation
|
The evaluation of the chronicity of the painful clinical picture and the disability that it involves was measured using the Graded Chronic Pain Scale of the DC / TMD, where I = Low intensity pain , without disability; II = High intensity pain, without disability; III = Moderate disability; IV = Severe disability.
|
It was applied in the initial evaluation
|
Occlusal discomfort associated with an occlusal splint at 2 weeks
Time Frame: It was applied in week 2 of intervention.
|
Scale responsible for evaluating adverse effects or discomfort of the subject to the occlusal splint during treatment, using a visual analog scale.
This scale has a score of 0 to 10, with 10 being the greatest discomfort experienced by the patient.
|
It was applied in week 2 of intervention.
|
Occlusal discomfort associated with an occlusal splint at 6 weeks
Time Frame: It was applied in week 6 of intervention.
|
Scale responsible for evaluating adverse effects or discomfort of the subject to the occlusal splint during treatment, using a visual analog scale.
This scale has a score of 0 to 10, with 10 being the greatest discomfort experienced by the patient.
|
It was applied in week 6 of intervention.
|
Occlusal discomfort associated with an occlusal splint at 10 weeks
Time Frame: It was applied in week 10 of intervention.
|
Scale responsible for evaluating adverse effects or discomfort of the subject to the occlusal splint during treatment, using a visual analog scale.
This scale has a score of 0 to 10, with 10 being the greatest discomfort experienced by the patient.
|
It was applied in week 10 of intervention.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Diego I De Nordenflycht, Universidad Nacional Andres Bello
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10.17605/OSF.IO/9XTMD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Study Data/Documents
-
Study Protocol
Information identifier: 10.17605/OSF.IO/9XTMDInformation comments: Supporting information for this study is available in the open science framework (OSF): the data set of individual participants, study protocol, statistical analysis plan, and informed consent form.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myalgia of Mastication Muscle
-
Universidad Nacional Andres BelloCompletedMyalgia of Mastication Muscle
-
Michigan State UniversityCompletedFocus of Study is to Determine Efficacy of CompexUnited States
-
University of SurreyCompletedMuscle Soreness | Muscle Strength | Muscle DamageUnited Kingdom
-
Indonesia UniversityNot yet recruitingMuscle Soreness | Stiffness of Elbow, Not Elsewhere ClassifiedIndonesia
-
David Grant U.S. Air Force Medical CenterCompleted
-
KU LeuvenCompletedMuscle Soreness | Muscle RecoveryBelgium
-
Naturex SAAtlantia Food Clinical TrialsCompletedPain | Muscle Soreness | Muscle DamageIreland
-
Mucos Pharma GmbH & Co. KGCompletedMuscle Soreness | Muscle Injury | Exercise Induced Muscle DamageGermany
-
University of Erlangen-Nürnberg Medical SchoolGerman Sport University, CologneCompletedMuscular Regeneration | Repeated Bout Effect of WB-EMSGermany
-
University of Texas Southwestern Medical CenterAbhimanyu Garg; Prishant Mishra; Jimin RenCompletedMuscle Weakness | Muscle Cramp | Muscle Stiffness | Statin-related Muscle Pain | Muscle AchesUnited States
Clinical Trials on behavioral and self-care therapy
-
University of Turin, ItalyCompleted
-
Kaiser PermanenteNational Institute of Mental Health (NIMH)CompletedBulimia | Eating DisordersUnited States
-
Babes-Bolyai UniversityCompletedSocial Anxiety DisorderRomania
-
University of ConnecticutMercer UniversityCompleted
-
University of California, Los AngelesRecruiting
-
Seoul National University HospitalNoom Inc.; InBodyCompletedSearch MeSHKorea, Republic of
-
University of California, San DiegoNational Institute of Mental Health (NIMH)Withdrawn
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
Islamia University of BahawalpurActive, not recruitingDepression | Chronic Heart FailurePakistan
-
CHU de Quebec-Universite LavalCanadian Breast Cancer Research AllianceCompleted